Literature DB >> 24853458

Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.

Miri Carmel1, Omer Zarchi2, Elena Michaelovsky3, Amos Frisch3, Miriam Patya3, Tamar Green4, Doron Gothelf5, Abraham Weizman6.   

Abstract

The 22q11.2 deletion syndrome (22q11.2DS) carries the highest genetic risk factor for the development of schizophrenia. We investigated the association of genetic variants in two schizophrenia candidate genes with executive function (EF) and IQ in 22q11.2DS individuals. Ninety two individuals with 22q11.2 deletion were studied for the genetic association between COMT and PRODH variants and EF and IQ. Subjects were divided into children (under 12 years old), adolescents (between 12 and 18 years old) and adults (older than 18 years), and genotyped for the COMT Val158Met (rs4680) and PRODH Arg185Trp (rs4819756) polymorphisms. The participants underwent psychiatric evaluation and EF assessment. Our main finding is a significant influence of the COMT Val158Met polymorphism on both IQ and EF performance. Specifically, 22q11.2DS subjects with Met allele displayed higher IQ scores in all age groups compared to Val carriers, reaching significance in both adolescents and adults. The Met allele carriers performed better than Val carriers in EF tasks, being statistically significant in the adult group. PRODH Arg185Trp variant did not affect IQ or EF in our 22q11.2DS cohort. In conclusion, functional COMT variant, but not PRODH, affects IQ and EF in 22q11.2DS subjects during neurodevelopment with a maximal effect at adulthood. Future studies should monitor the cognitive performance of the same individuals from childhood to old age.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  22q11.2DS; COMT; Executive function (EF); Intelligence quotient (IQ)

Mesh:

Substances:

Year:  2014        PMID: 24853458     DOI: 10.1016/j.jpsychires.2014.04.019

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  8 in total

1.  PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.

Authors:  Mariken B de Koning; Esther D A van Duin; Erik Boot; Oswald J N Bloemen; Jaap A Bakker; Kathryn M Abel; Thérèse A M J van Amelsvoort
Journal:  Psychopharmacology (Berl)       Date:  2015-06-12       Impact factor: 4.530

2.  The use of two different MLPA kits in 22q11.2 deletion syndrome.

Authors:  L J M Evers; J J M Engelen; L M H Houben; L M G Curfs; T A M J van Amelsvoort
Journal:  Eur J Med Genet       Date:  2016-02-24       Impact factor: 2.708

3.  Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations.

Authors:  Jonathan H Chung; Jinlu Cai; Barrie G Suskin; Zhengdong Zhang; Karlene Coleman; Bernice E Morrow
Journal:  Hum Mutat       Date:  2015-07-02       Impact factor: 4.878

Review 4.  Molecular genetics of 22q11.2 deletion syndrome.

Authors:  Bernice E Morrow; Donna M McDonald-McGinn; Beverly S Emanuel; Joris R Vermeesch; Peter J Scambler
Journal:  Am J Med Genet A       Date:  2018-10       Impact factor: 2.802

Review 5.  A cross-comparison of cognitive ability across 8 genomic disorders.

Authors:  Michael Mortillo; Jennifer G Mulle
Journal:  Curr Opin Genet Dev       Date:  2021-05-31       Impact factor: 4.665

6.  Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach.

Authors:  Elena Michaelovsky; Miri Carmel; Amos Frisch; Mali Salmon-Divon; Metsada Pasmanik-Chor; Abraham Weizman; Doron Gothelf
Journal:  Transl Psychiatry       Date:  2019-01-17       Impact factor: 6.222

7.  Lower [18F]fallypride binding to dopamine D2/3 receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study.

Authors:  Esther D A van Duin; Jenny Ceccarini; Jan Booij; Zuzana Kasanova; Claudia Vingerhoets; Jytte van Huijstee; Alexander Heinzel; Siamak Mohammadkhani-Shali; Oliver Winz; Felix Mottaghy; Inez Myin-Germeys; Thérèse van Amelsvoort
Journal:  Psychol Med       Date:  2019-04-02       Impact factor: 7.723

8.  Autoinflammatory Keratinization Disease With Hepatitis and Autism Reveals Roles for JAK1 Kinase Hyperactivity in Autoinflammation.

Authors:  Takuya Takeichi; John Y W Lee; Yusuke Okuno; Yuki Miyasaka; Yuya Murase; Takenori Yoshikawa; Kana Tanahashi; Emi Nishida; Tatsuya Okamoto; Komei Ito; Yoshinao Muro; Kazumitsu Sugiura; Tamio Ohno; John A McGrath; Masashi Akiyama
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.